Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    alzheimer, comentis
Show Display Options
Rank Status Study
1 Completed GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: DMXB-A
2 Completed Safety Study of CTS21166 to Treat Alzheimer Disease
Condition: Alzheimer's Disease
Intervention: Drug: CTS21166 (ZPQ-21166)

Study has passed its completion date and status has not been verified in more than two years.